… A systematic literature review and meta-analysis were conducted to assess vedolizumab
real-world effectiveness and safety in patients with ulcerative colitis (UC) or Crohn’s disease (…

… on Efficacy and of Vedolizumab in Patients With Inflammatory Bowel Disease study is a cohort
… Here, we report the effectiveness and safety of vedolizumab induction therapy in patients …

… This article presents the efficacy and safety results after week … Herein, we report the efficacy
and safety results of the … safety profile. We also demonstrated that the IBD-related systemic …

… The incidence of older onset inflammatory bowel disease (IBD), typically defined … Effectiveness
and safety of vedolizumab induction therapy for patients with inflammatory bowel disease…

… We previously reported the effectiveness and safety of vedolizumab in patients in this
cohort at weeks 14 and 52. Here, we report the effectiveness and safety of vedolizumab …

… Through this multicentre nationwide study we aimed to evaluate the real effectiveness of …
the long-term effectiveness of vedolizumab and to determine the safety of this drug in a …

… to summarize the effectiveness and safety of ustekinumab in inflammatory bowel disease
(IBD) … , we sought to summarize effectiveness in perianal disease and to examine pregnancy …

… the plateau of drug efficacy in inflammatory bowel disease (IBD). We conducted a systematic
review and meta-analysis to assess the safety and effectiveness of dual biologic therapy (…

Background and Aims There is a need to evaluate the benefit-risk ratio of current therapies
in inflammatory bowel disease (IBD) patients to provide the best quality of care. The primary …

… ultimately achieves the effect of suppressing intestinal inflammation. This study aimed to
evaluate the efficacy and safety of vedolizumab in the treatment of inflammatory bowel disease. …